KATMED · Checked.be

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of KATMED is 0.2% (very low). The 2025 annual accounts show equity of €206k and a net result of €16k. Equity is growing by ~23.3% per year across the filed fiscal years. Its solvency ranks better than 71% of 2219 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Signals

2 signals · with evidence

Consistently profitable

Positive net result in the two most recent financial years (2024 and 2025).

View the result trend

Growing equity

Equity grew over 2023-2025. Profits are largely retained rather than distributed.

View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-06-2026, 56 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

How we compute the deadline

The year end is derived from 4 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	05-06-2026	56 d early	2026-00141724
31-12-2024	31-07-2025	11-07-2025	20 d early	2025-00289846
31-12-2023	31-07-2024	20-09-2024	51 d late	2024-00467626
31-12-2022	31-07-2023	21-08-2023	21 d late	2023-00341031

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

More than 3 years active

Founded in 2021, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

0.2% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Young company +Multiple establishment units +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€16k-59.9%

Working capital€230k+28.3%

CSV export

Annual accounts & ratios

Source: NBB · 2025

Annual accounts filed on 05-06-2026 with the NBB · fiscal year 2025 · micro

Operating resultNet result

Trajectory (indicative)

Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.

growing Equity: growth of ~23.3%/year over 4 fiscal years, indicative, assuming unchanged policy.

Solid line = filed figures · dashed = extended trend · area = indicative range.

How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison

Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	79.8%	58.2%	better than 71% of 2219 sector peers
Net result	€16k	€60k	better than 18% of 2217 sector peers
Equity	€206k	€74k	better than 78% of 2219 sector peers
Gross operating margin	€86k	€95k	better than 46% of 2219 sector peers
Total assets	€258k	€187k	better than 64% of 2219 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

Sector position over time

Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).

Solvency P71

Weakening position over 2022-2025 · n=2219-6584

Net result P18

Weakening position over 2022-2025 · n=2217-6578

Equity P78

Improving position over 2022-2025 · n=2219-6584

Gross operating margin P46

Weakening position over 2022-2025 · n=2219-6586

Describes the position versus peers, not a forecast.

EBITDA

€39k

-27.1% 22-25

Net profit

€16k

-59.9% 22-25

Cash flow

€24k

-45.0% 22-25

Total assets

€258k

+26.4% 22-25

Equity

€206k

+7.9% 22-25

Working capital

€230k

+28.3% 22-25

Employees (FTE)

0

- 22-25

Staff costs

€6k

+4.2% 22-25

Show 11 other metrics

Income taxes

€16k

+39.1% 22-25

Dividends

€833

0.0% 22-25

Debt

€6k

-52.6% 22-25

Debt ≤ 1y

€6k

-58.3% 22-25

Current ratio

42.56

+193.1% 22-25

Quick ratio

42.56

+193.1% 22-25

Solvency

79.8%

-14.6% 22-25

Debt / equity

0.03

-56.1% 22-25

ROE

7.8%

-62.8% 22-25

ROA

6.2%

-68.3% 22-25

Interest coverage

25.41

-60.2% 22-25

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2025
Deposit	micro
Revenue	-
EBITDA	€39k
Net profit	€16k
Cash flow	€24k
Staff costs	-
Income taxes	€16k
Dividends	€833
Total assets	€258k
Equity	€206k
Debt	€6k
of which ≤ 1y	€6k
of which > 1y	-
Working capital	€230k
Employees (FTE)	-

Ratios (computed)

	2025
Current ratio	42.56
Quick ratio	42.56
Working capital ratio	89.0%
Solvency	79.8%
Debt / equity	0.03
Long-term debt ratio	-
Interest coverage	25.41
Gross margin	-
Net margin	-
ROA	6.2%
ROE	7.8%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2025

Assets

Fixed assets €23k · 8.8% Current assets €235k · 91.2%

Equity & liabilities

Equity €206k · 79.8% Provisions €46k · 17.7% Debt €6k · 2.4%

Full annual accounts (23 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€258k
Fixed assets	21/28	€23k
Tangible fixed assets	22/27	€22k
Financial fixed assets	28	€300
Current assets	29/58	€235k
Amounts receivable within one year	40/41	€97k
Cash & bank	54/58	€127k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€258k
Equity	10/15	€206k
Contributions / capital	10/11	€4k
Accumulated profits (losses)	14	€202k
Provisions & deferred taxes	16	€46k
Amounts payable	17/49	€6k
Amounts payable within one year	42/48	€6k
Trade debts payable within one year	44	€3k
Income statement
Gross operating margin	9900	€86k
Operating result	9901	€31k
Financial income	75	€3k
Financial charges	65	€2k
Result before taxes	9903	€32k
Income taxes	67/77	€16k
Net result for the period	9904	€16k
Result to be appropriated	9905	€16k

This table shows the latest fiscal year. 3 prior years, with figures and ratios, belong to a paid plan. See plans →

Ratios computed by Checked.

Health barometer

FY 2025 · computed

86 / 100 Excellent

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Directors

Directors & mandates

1 director

2 of this company's 2 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing below: a director who resigned there may therefore still show here as sitting. See the acts under Publications.

Current directors & mandates

Xavier François C. Rygaert
Director
State Gazette act 24163364 (19-11-2024)

Current
01-01-2024 → present

Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary	Activiteiten van medisch specialisten(86220)
Legal form	Private limited company(610)
Incorporation	29-12-2021
Status	Active
Postal code	1780

Structure & network

Locations & real estate

Registered office

on the map · from the address register

exact location from the address register On OpenStreetMap

Establishment units

2 locations

KATMED

A. De Boecklaan 36, 1780 WemmelActiviteiten van medisch specialisten

since 20212.327.998.020

MediNOH

Ijzerkruisenlaan 11, 1120 BrusselActiviteiten van huisartspraktijken

since 20222.332.873.061

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels2

Ground area1,343 m²

Buildings2

Building footprint198 m²

Volume (LiDAR)1,923 m³

Tallest building13.3 m · ±4 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (50%) Brussels 1 (50%)